Onivyde (nanoliposomal irinotecan) / Ipsen, Servier, Yakult Honsha, Takeda, PharmaEngine  >>  Phase 1
Welcome,         Profile    Billing    Logout  

9 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Onivyde (nanoliposomal irinotecan) / Servier, Ipsen
NCT04258072: Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.

Recruiting
1b
24
RoW
Vactosertib, TEW-7197
Samsung Medical Center
Pancreas Cancer
12/22
03/23
NCT02022644: Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma

Completed
1
18
US
nanoliposomal irinotecan, MM-398, ONIVYDE
University of California, San Francisco, Ipsen, National Cancer Institute (NCI)
High Grade Glioma
12/20
05/23
NCT03703063: Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

Recruiting
1
30
US
Gemcitabine, Gemzar, nab paclitaxel, Abraxane, Onivyde, Leucovorin, 5-fu
Benaroya Research Institute
Pancreatic Adenocarcinoma
09/21
09/22
NCT03810742: Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

Completed
1
44
RoW
Nanoliposomal Irinotecan, TAS-102
PharmaEngine
Refractory Solid Tumors
05/22
10/23
NCT02013336: Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

Recruiting
1
30
US
MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
South Plains Oncology Consortium
Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma, Neuroblastoma, Osteosarcoma
12/23
12/23
NCT03554707: SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Not yet recruiting
1
6
US
SGT-53, Radiation, Irinotecan, Camptosar, Onivyde, Temozolomide, Temodar, Bevacizumab, Avastin
SynerGene Therapeutics, Inc.
Childhood CNS Tumor
12/23
12/24
SIRACUSA, NCT05383352: A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Recruiting
1
122
Europe, RoW
Irinotecan liposome injection, Onivyde® Reference product, Onivyde Test product, Folinic Acid, Leucovorin (LV), 5-Fluorouracil, 5-FU
Ipsen
Metastatic Pancreatic Adenocarcinoma
05/24
09/24
NCT02631733: Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Active, not recruiting
1
48
US
Ferumoxytol, Feraheme, Ferumoxytol Non-Stoichiometric Magnetite, Irinotecan Sucrosofate, inotecan Hydrochloride as Sucrosulfate Salt Form Liposomal Formulation, Irinotecan Liposome, Irinotecan Sucrosofate Liposome, Irinotecan Sucrosofate-containing Pegylated Liposomal Formulation, MM 398, MM-398, MM398, nal-IRI, Nanoliposomal Irinotecan, Nanoliposomal Irinotecan as Sucrosofate, Nanoparticle Liposome Formulation of Irinotecan, Onivyde, PEP-02, PEP02, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Veliparib, ABT-888, PARP-1 inhibitor ABT-888
National Cancer Institute (NCI)
Malignant Solid Neoplasm
07/24
07/24
PIPAC-NAL-IRI, NCT05277766: Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Recruiting
1
45
Europe
PIPAC with Nal-IRI, Onivyde
University Hospital, Ghent, Kom Op Tegen Kanker, University Ghent
Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer, Small Bowel Cancer, Appendix Cancer, Gastric Cancer, Pancreatic Cancer, Bile Duct Cancer
08/25
01/27

Download Options